Gambogic acid affects high glucose-induced apoptosis and inflammation of retinal endothelial cells through the NOX4/NLRP3 pathway

Background This study aimed to investigate the effect and mechanism of gambogic acid (GA) on the apoptosis and inflammation of human retinal endothelial cells (HRECs) under high glucose conditions. Methods HRECs were cultured in a high glucose medium to simulate retinal endothelial cell injury induced by diabetic retinopathy. Flow cytometry was used to analyze the apoptosis level of HRECs. Cell viability was detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). Western blotting was applied to detect the intracellular apoptosis-related proteins and expression levels of NADPH oxidase 4 (NOX4), nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3), and interleukin (IL)-1β. Enzyme linked immunosorbent assay (ELISA) was utilized to detect the expression of IL-6, IL-8, IL-10, and tumor necrosis factor-α (TNF-α) in the cell supernatants. The messenger RNA (mRNA) levels of IL-6, IL-8, IL-10, and TNF-α were detected by reverse transcription-polymerase chain reaction (RT-qPCR). Results We observed that high glucose induced the apoptosis and inflammation of HRECs. In addition, the high glucose environment promoted NOX/NLRP3 pathway activation. The activity of HRECs was not significantly affected by the presence of 20 μM or less of GA, and 15 μM of GA could restore the diminished activity of HRECs induced by high glucose. The apoptosis of HRECs cultured under high glucose conditions was significantly inhibited (P<0.05), the levels of IL-6, IL-8, and TNF-α in the cell supernatant were significantly decreased (P<0.05), and the levels of IL-10 were significantly increased (P<0.05). Meanwhile, the relative mRNA expression levels of IL-6, IL-8, and TNF-α in HRECs were significantly decreased (P<0.05), while those of IL-10 were significantly increased (P<0.05). The activity of the high glucose-induced NOX4/NLRP3 pathway in HRECs was significantly inhibited after treatment with 15 μM of GA (P<0.05). Following activation of the NOX4/NLRP3 pathway in HRECs, the apoptosis level was significantly increased (P<0.05), and the inflammatory response was aggravated (P<0.05). Inhibiting the activity of the intracellular NOX4/NLRP3 pathway markedly inhibited cell apoptosis and the inflammatory response (P<0.05). Conclusions GA can inhibit the apoptosis and inflammation of HRECs under high glucose conditions by inhibiting the activity of the NOX4/NLRP3 pathway. This has a significant inhibitory effect on diabetic retinopathy, which is worthy of further study.

[1]  Mingtao Zhu,et al.  Research Progress in the Field of Gambogic Acid and Its Derivatives as Antineoplastic Drugs , 2022, Molecules.

[2]  Sopida Thipsawat Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature , 2021, Diabetes & vascular disease research.

[3]  Kunlun Huang,et al.  Efficacy and Mechanisms of Oleuropein in Mitigating Diabetes and Diabetes Complications. , 2021, Journal of agricultural and food chemistry.

[4]  G. Dong,et al.  The contribution of type 2 diabetes mellitus to hypothalamic inflammation and depressive disorders in young patients with obesity , 2021, Annals of translational medicine.

[5]  Tien-Jyun Chang,et al.  Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy , 2020, Journal of diabetes investigation.

[6]  Murali M. Yallapu,et al.  Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics. , 2020, Biochimica et biophysica acta. Reviews on cancer.

[7]  Dandan Huang,et al.  A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[8]  M. Hu,et al.  Protective effects of acarbose against vascular endothelial dysfunction through inhibiting Nox4/NLRP3 inflammasome pathway in diabetic rats. , 2019, Free radical biology & medicine.

[9]  A. Dabrowska,et al.  Therapeutic potential of curcumin in eye diseases , 2019, Central-European journal of immunology.

[10]  Lei Zhang,et al.  Effect of Astragalus polysaccharide in treatment of diabetes mellitus: a narrative review. , 2019, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

[11]  Hongyan Li,et al.  Silencing astrocyte elevated gene‐1 attenuates lipopolysaccharide‐induced inflammation and mucosal barrier injury in NCM460 cells by suppressing the activation of NLRP3 inflammasome , 2019, Cell biology international.

[12]  Zhi Shan,et al.  Gambogic acid inhibits LPS-induced macrophage pro-inflammatory cytokine production mainly through suppression of the p38 pathway , 2018, Iranian journal of basic medical sciences.

[13]  Wei Wang,et al.  Diabetic Retinopathy: Pathophysiology and Treatments , 2018, International journal of molecular sciences.

[14]  P. Fort,et al.  Role of Inflammation in Diabetic Retinopathy , 2018, International journal of molecular sciences.

[15]  Lihua Liu,et al.  Naringin attenuates diabetic retinopathy by inhibiting inflammation, oxidative stress and NF-κB activation in vivo and in vitro , 2017, Iranian journal of basic medical sciences.

[16]  J. Ong,et al.  Asymmetric diabetic retinopathy , 2010, Journal of diabetes.

[17]  G. Trick,et al.  Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[18]  Shuiqing Hu,et al.  Gambogic acid ameliorates diabetes‐induced proliferative retinopathy through inhibition of the HIF‐1&agr;/VEGF expression via targeting PI3K/AKT pathway , 2018, Life sciences.